These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 16686329)

  • 21. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?
    Madhusoodanan S; Shah P; Brenner R; Gupta S
    CNS Drugs; 2007; 21(2):101-15. PubMed ID: 17284093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument.
    Ballard C; Cream J
    Int Psychogeriatr; 2005 Mar; 17(1):4-12; discussion 22-9. PubMed ID: 15945588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe behavioral and psychological symptoms of dementia successfully treated at home with a blonanserin transdermal patch: A case report.
    Yamaguchi J; Sadahiro R; Hirayama T; Wada S; Nakahara R; Matsuoka H
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):474-478. PubMed ID: 38558544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
    Wightman R; Fielding J; Green S
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Behavioural and psychological symptoms in dementia in Alzheimer's disease].
    Benoit M; Robert P
    Rev Prat; 2005 Nov; 55(17):1895-901. PubMed ID: 16396230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and Psychological Signs and Symptoms of Dementia (BPSD) in antipsychotic-naïve Alzheimer's Disease patients.
    Suh GH; Kim SK
    Int Psychogeriatr; 2004 Sep; 16(3):337-50. PubMed ID: 15559757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence.
    Kim Y; Wilkins KM; Tampi RR
    Drugs Aging; 2008; 25(3):187-96. PubMed ID: 18331071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in clinical manifestations and outcomes among hospitalized patients with behavioral and psychological symptoms of dementia.
    Kitamura T; Kitamura M; Hino S; Tanaka N; Kurata K
    J Clin Psychiatry; 2012 Dec; 73(12):1548-54. PubMed ID: 23290328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New therapeutic strategies for behavioral and psychological symptoms of dementia].
    Ikeda M
    Rinsho Shinkeigaku; 2005 Nov; 45(11):861-3. PubMed ID: 16447746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone and dementia-related aggression: new indication. A last resort, no better than haloperidol.
    Prescrire Int; 2009 Dec; 18(104):248. PubMed ID: 20025088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.
    Popp J; Arlt S
    Curr Opin Psychiatry; 2011 Nov; 24(6):556-61. PubMed ID: 21934621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer disease: Non-pharmacological and pharmacological management of cognition and neuropsychiatric symptoms.
    Loi SM; Eratne D; Kelso W; Velakoulis D; Looi JC
    Australas Psychiatry; 2018 Aug; 26(4):358-365. PubMed ID: 29671334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of behavioral disorders in dementia patients].
    Lebert F; Robert P; Rigaud AS
    Rev Neurol (Paris); 2000 Sep; 156(8-9):767-72. PubMed ID: 10992121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Krüger-Rainer C; Haushofer M; Mucke HA
    CNS Drugs; 2004; 18(15):1165. PubMed ID: 15581386
    [No Abstract]   [Full Text] [Related]  

  • 37. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
    Pinto T; Lanctôt KL; Herrmann N
    Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
    Ruths S; Straand J; Nygaard HA; Aarsland D
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):889-95. PubMed ID: 18306150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotics for BPSD: an audit of prescribing practice in a specialist psychiatric inpatient unit.
    Haw C; Stubbs J; Yorston G
    Int Psychogeriatr; 2008 Aug; 20(4):790-9. PubMed ID: 18307825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers.
    Cornegé-Blokland E; Kleijer BC; Hertogh CM; van Marum RJ
    J Am Med Dir Assoc; 2012 Jan; 13(1):80.e1-6. PubMed ID: 21450216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.